Skip to main content
. 2022 Jun;14(6):2276–2296. doi: 10.21037/jtd-21-1740

Table 2. Summary of systemic analgesic options for acute perioperative pain control with benefits, cautions, and considerations for use in thoracotomy and thoracoscopic surgical approaches.

Drug Benefits Cautions Thoracotomy Thoracoscopy
Acetaminophen Safe, synergistic with NSAIDs, effective for referred shoulder pain Low-risk without significant adverse effects, caution if significant liver disease Use unless contraindicated Use unless contraindicated
NSAIDs Opioid-sparing, synergistic with acetaminophen Risk of bleeding, AKI, and GI mucosal damage Use unless contraindicated Use unless contraindicated
Ketamine Opioid-sparing, synergistic with opioids, avoids respiratory depression Hallucinations, nightmares Consider in select patients (e.g., chronic pain on opioid therapy, contraindication to TEA) Consider in select patients (e.g., chronic pain on opioid therapy, not candidate for other adjuncts)
Gabapentinoids Possibly opioid-sparing, questionable clinical significance Risk of sedation, respiratory depression with opioids Avoid unless on prior to surgery Avoid unless on prior to surgery
IV Lidocaine Potential anti-inflammatory effect, pre-emptive topical effect Risk of local anesthetic systemic toxicity Consider if not using regional local anesthetics, but unclear benefit Consider if not using regional local anesthetics, but unclear benefit
Dexamethasone Opioid-sparing analgesic effects, PONV prophylaxis Hyperglycemia Use unless contraindicated Use unless contraindicated
Opioids Analgesia Respiratory depression, sedation, constipation, tolerance, dependence Use as needed (e.g., PCA, oral opioids with IV for breakthrough pain) Use as needed (e.g., PCA, oral opioids with IV for breakthrough pain)

NSAID, non-steroidal anti-inflammatory drug; AKI, acute kidney injury; GI, gastrointestinal; TEA, thoracic epidural analgesia; PONV, post-operative nausea and vomiting; PCA, patient-controlled analgesia; IV, intravenous.